THE LATEST IN WOMEN’S HEALTH
Capabilities for Clinical Studies in the Genitourinary Syndrome of Menopause (GSM)
HDauthor
2018-08-23T14:01:23+00:00
WHAT WE DO
Health Decisions is a full-service CRO providing extensive clinical development expertise and comprehensive services for bringing women’s health and diagnostics to market rapidly, efficiently and with minimal risk.
SERVICES
Trial Management
Trial Management
Health Decisions provides proactive project management for phase 1 – 4 trials of women’s health drugs as well as trials of devices and diagnostics for all therapeutic areas.
Monitoring
Monitoring
Health Decisions utilizes a monitoring approach based on team-work between field and in-house CRAs that ensures high data-quality and improves site performance.
Data and Quality Management
Data and Quality Management
The experienced Health Decisions data management and quality management groups ensure collection and delivery of high-quality data for each study.
Biostatistics
Biostatistics
Health Decisions’ biostatisticians provide statistical planning, design, programming and analysis to ensure that each study meets informational goals.
Study Design and Protocol Development
Study Design and Protocol Development
The Health Decisions biostatistical and clinical teams have extensive expertise in protocol development for phase 1 – 4 trials of therapeutics as well as for diagnostics trials.
Consulting
Consulting
Health Decisions’ experts provide medical, biostatistical, operational and regulatory consulting services to assist sponsors at every stage of clinical development.
BUILDING THE WORLD’S LEADING CRO IN WOMEN’S HEALTH AND DIAGNOSTICS
“Health Decisions is committed to building the world’s leading CRO in women’s health and diagnostics. We have collaborated effectively with many innovative sponsors of women’s health and diagnostic products. Our leadership team and clinical development experts are truly passionate about improving women’s health and interested in learning how we can bring your product to market rapidly with minimal cost and risk. We are equally passionate about assisting diagnostics developers in efficiently demonstrating the clinical validity and utility of their products.” Patrick Phillips, BSc (Hons), D.Phil., Chief Executive Officer
What Women’s Health Means to Us
The Importance of Diagnostics to Health Decisions
- Health Decisions and Comac Medical Strengthen Strategic Alliance for Women’s Health Trials HDauthor 2018-08-22T18:31:27+00:00
Health Decisions and Comac Medical Strengthen Strategic Alliance for Women’s Health Trials
- Women’s Health Specialty CRO Health Decisions Active at DIA 2018 HDauthor 2018-07-25T17:48:37+00:00
Women’s Health Specialty CRO Health Decisions Active at DIA 2018
- Health Decisions Announces Webinar on Specialty CRO Selection HDauthor 2018-07-25T17:48:42+00:00
Health Decisions Announces Webinar on Specialty CRO Selection
- Health Decisions Celebrates National Women’s Health Week with Diverse Program HDauthor 2018-07-25T17:49:08+00:00
Health Decisions Celebrates National Women’s Health Week with Diverse Program
- Webinar Offers PI and Patient Perspectives on HMB Clinical Trials HDauthor 2018-07-25T17:49:17+00:00
Webinar Offers PI and Patient Perspectives on HMB Clinical Trials
- CRO Health Decisions Sponsors 5K Run/Walk for Women at ACOG 2018 Annual Meeting HDauthor 2018-07-25T17:49:29+00:00
CRO Health Decisions Sponsors 5K Run/Walk for Women at ACOG 2018 Annual Meeting
- Health Decisions’ CMO Andrea Lukes Accepts Health Care Heroes Award HDauthor 2018-03-12T14:46:00+00:00
Health Decisions’ CMO Andrea Lukes Accepts Health Care Heroes Award
- Next Generation Dx Summit August 20 – 24, 2018, Washington, DC HDauthor 2017-12-12T18:28:42+00:00
Next Generation Dx Summit August 20 – 24, 2018, Washington, DC
- Annual Meeting of the North American Menopause Society Oct 3 – 6, 2018, San Diego, CA HDauthor 2017-12-13T14:30:50+00:00
Annual Meeting of the North American Menopause Society Oct 3 – 6, 2018, San Diego, CA
- American Society of Reproductive Medicine (ASRM) Scientific Congress & Expo 2018 October 6 – 10, Denver, CO HDAuthor 2017-12-12T18:29:54+00:00
American Society of Reproductive Medicine (ASRM) Scientific Congress & Expo 2018 October 6 – 10, Denver, CO
- Association for Molecular Pathology (AMP) 2018 Annual Meeting November 1 – 3, San Antonio, TX HDAuthor 2017-12-13T14:43:48+00:00
Association for Molecular Pathology (AMP) 2018 Annual Meeting November 1 – 3, San Antonio, TX
- Capabilities for Clinical Studies in Endometriosis HDauthor 2018-08-23T13:59:51+00:00
Capabilities for Clinical Studies in Endometriosis
- Capabilities for Clinical Studies in Female Sexual Dysfunction HDauthor 2018-08-24T16:28:24+00:00
Capabilities for Clinical Studies in Female Sexual Dysfunction
- Dual 510(k)/CLIA Waiver Study of a POC Test HDAuthor 2018-08-23T14:57:09+00:00
Dual 510(k)/CLIA Waiver Study of a POC Test
- Capabilities for Clinical Studies in Osteoporosis HDauthor 2018-08-23T20:18:19+00:00
Capabilities for Clinical Studies in Osteoporosis
- Capabilities for Clinical Studies in Contraception HDauthor 2018-09-18T15:33:22+00:00
Capabilities for Clinical Studies in Contraception
- Case Study of a Bacterial Vaginosis Trial HDauthor 2018-08-24T15:08:02+00:00
Case Study of a Bacterial Vaginosis Trial
- Diagnostics Development Services HDAuthor 2018-08-23T14:59:00+00:00
Diagnostics Development Services
- Capabilities for Clinical Studies in the Genitourinary Syndrome of Menopause (GSM) HDauthor 2018-08-23T14:01:23+00:00
Capabilities for Clinical Studies in the Genitourinary Syndrome of Menopause (GSM)
- Capabilities in Women’s Health Studies HDAuthor 2018-08-23T14:51:02+00:00
Capabilities in Women’s Health Studies
- Large PMA Study of a Colorectal Cancer Diagnostic HDAuthor 2018-07-25T17:49:49+00:00
Large PMA Study of a Colorectal Cancer Diagnostic
- Addressing the New Imperative to Include Females in Clinical Trials HDAuthor 2018-08-01T17:20:44+00:00
Addressing the New Imperative to Include Females in Clinical Trials
- Nine Tips for Success in Precision Medicine HDAuthor 2018-03-28T21:32:57+00:00
Nine Tips for Success in Precision Medicine
- Ten Tips for Establishing the Clinical Utility of Molecular Diagnostics HDAuthor 2018-08-23T14:43:28+00:00
Ten Tips for Establishing the Clinical Utility of Molecular Diagnostics
- LiveTrial Data Management as a Service HDAuthor 2017-10-03T21:30:50+00:00
LiveTrial Data Management as a Service
- Perfecting Phase 2: Ten Essential Steps HDAuthor 2017-10-03T21:31:02+00:00
Perfecting Phase 2: Ten Essential Steps
- 510(k) Study of a Respiratory Diagnostic HDAuthor 2018-08-23T14:44:36+00:00
510(k) Study of a Respiratory Diagnostic
- Federal Contracting Capabilities Overview HDAuthor 2017-10-03T21:35:19+00:00
Federal Contracting Capabilities Overview
- Capabilities in Early Phase Studies HDAuthor 2017-10-03T21:35:28+00:00
Capabilities in Early Phase Studies
- Pivotal Study of an Alzheimer’s Drug HDAuthor 2017-10-03T21:37:17+00:00
Pivotal Study of an Alzheimer’s Drug
- Capabilities in Gastroenterology Studies HDAuthor 2017-10-03T21:37:27+00:00
Capabilities in Gastroenterology Studies
- Phase 2c: Expedited Development for All HDAuthor 2018-07-26T16:16:35+00:00
Phase 2c: Expedited Development for All
Recent Tweets
- Is a Specialty CRO Right for You? healthdec_rljyp3 2018-08-22T18:32:39+00:00
Is a Specialty CRO Right for You?
- Webinar: Heavy Menstrual Bleeding – Medical Background and PI and Patient Perspectives on Clinical Trials healthdec_rljyp3 2018-08-23T20:39:43+00:00
Webinar: Heavy Menstrual Bleeding – Medical Background and PI and Patient Perspectives on Clinical Trials
- Webinar: Critical Success Factors in Reproductive Health Studies – Practical Tips for Minimizing Timelines, Risk and Costs healthdec_rljyp3 2018-08-23T20:40:49+00:00
Webinar: Critical Success Factors in Reproductive Health Studies – Practical Tips for Minimizing Timelines, Risk and Costs
- Webinar: Key Tips for Diagnostics in 2018 and Beyond – Development Success in the Evolving US and EU Landscape healthdec_rljyp3 2018-08-23T20:43:28+00:00
Webinar: Key Tips for Diagnostics in 2018 and Beyond – Development Success in the Evolving US and EU Landscape
